Dr Akira Miyawaki Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2020)
- Ebitda
- Net Worth
- Total Assets -15.38%
(FY 2020)
About Dr Akira Miyawaki Foundation
The Company is engaged in the Forest & Wildlife Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Musthafa Kasim and Thiruneelakandan Selvamani serve as directors at the Company.
- CIN/LLPIN
U02000TN2016NPL110610
- Company No.
110610
- Company Classification
Private Not For Profit Company
- Incorporation Date
26 May 2016
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr Akira Miyawaki Foundation?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Musthafa Kasim | Director | 26-May-2016 | Current |
Thiruneelakandan Selvamani | Director | 26-May-2016 | Current |
Financial Performance of Dr Akira Miyawaki Foundation.
Dr Akira Miyawaki Foundation, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Dr Akira Miyawaki Foundation?
Unlock access to Dr Akira Miyawaki Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Rahmath Pathipagam (Chennai) Private LimitedActive 17 years 5 months
Musthafa Kasim is a mutual person
- Kavikko Pathipagam Private LimitedActive 3 years 1 month
Musthafa Kasim and Thiruneelakandan Selvamani are mutual person
- Asian Exchange (India) Private LimitedActive 16 years 8 months
Thiruneelakandan Selvamani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr Akira Miyawaki Foundation?
Unlock and access historical data on people associated with Dr Akira Miyawaki Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Akira Miyawaki Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Akira Miyawaki Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.